🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Migraine With Aura

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals NCT07022496Phase 41 site📍 Cairo Ain Shams University · Tests: Caffeine (200 mg), triptans, NSAID (Nonsteroidal anti-inflammatory drugs), Paracetamol (acetaminophen) Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults NCT07792681Phase 2, Phase 383 sites📍 Shanxi📍 Inner Mongolia📍 Beijing Brise Pharmaceuticals Co., Ltd. · Tests: BR005-036C, BR005-036C, Placebo Trial Designs for Evaluating Migraine Treatment NCT06617832NA2 sites📍 Aarhus C📍 Aarhus N University of Aarhus · Tests: Active drug for acute migraine treatment, Placebo Oral Tablet Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide NCT07021859NA1 site📍 Glostrup Municipality Danish Headache Center · Tests: Calcitonin-gene related peptide (CGRP), Placebo Neurogenetic And Hemodynamic Of Migraine Aura And Pfo NCT07349004n/a1 site📍 Bologna Azienda Usl di Bologna · Tests: Intervention Gepant treAtments: EffectIveNess and tolERability (GAINER) NCT05903027n/a2 sites📍 Florence📍 Pavia University of Florence · Tests: Rimegepant 75 MG Disintegrating Oral Tablet Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) NCT05125302Phase 3129 sites📍 Huntsville📍 Saraland📍 Phoenix AbbVie · Tests: Ubrogepant, Placebo-Matching Ubrogepant Study of EVO756 in Adults With Migraine NCT07616128Phase 235 sites📍 Chandler📍 Buena Park📍 Fresno Evommune, Inc. · Tests: EVO756, Dose 1, EVO756, Dose 2, Placebo Randomized Study in Children and Adolescents With Migraine: Acute Treatment NCT04649242Phase 3246 sites📍 Birmingham📍 Scottsdale📍 Tempe Pfizer · Tests: Rimegepant/BHV3000, Matching placebo Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD NCT07348783NA1 site📍 Huddinge Karolinska Institutet · Tests: Intervention yoga based exercises RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment NCT06409832n/a2 sites📍 Florence📍 Pavia University of Florence · Tests: Rimegepant 75 mg Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine NCT04743141Phase 3124 sites📍 Scottsdale📍 Tempe📍 Anaheim Pfizer · Tests: Rimegepant (PF-07899801) Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification NCT06674772n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Saliva test BE WELL With Migraine: Brain Education and WELLness With Migraine NCT05987592NA3 sites📍 Cambridge📍 Winston-Salem📍 Cincinnati Wake Forest University Health Sciences · Tests: Brain Education and WELLness with Migraine Group A, Brain Education and WELLness with Migraine Group B Responding With Evidence and Access for Childhood Headaches NCT05889624NA15 sites📍 Birmingham📍 Phoenix📍 San Francisco Children's Hospital Medical Center, Cincinnati · Tests: CBT, Amitriptyline New Methods for Evaluating Preventive Migraine Treatment NCT07071506NA2 sites📍 Aarhus C📍 Aarhus N University of Aarhus · Tests: Active drug for chronic migraine treatment., Placebo Subcutaneous injection A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine NCT06203873NA2 sites📍 Beijing📍 Beijing Chinese Academy of Medical Sciences, Fuwai Hospital · Tests: Biodegradable occluder, Metal occluder Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura NCT04063540Phase 25 sites📍 Bron📍 Clermont-Ferrand📍 Marly Centre Hospitalier Universitaire de Nice · Tests: Amiloride, Placebos Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study NCT06972056Phase 437 sites📍 Hazel Green📍 Flagstaff📍 Phoenix Mayo Clinic · Tests: Atogepant 60 mg, Propranolol 160 mg, Topiramate 100 mg
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy